242 results
8-K
EX-99.1
LADX
LadRx Corp
17 May 11
CytRx Completes Sale of Molecular Chaperone Assets to Orphazyme ApS in Deal Worth up to $120 Million
12:00am
represent substantial return on investment as CytRx executes on monetization strategy to support advancement of oncology programs –
– Completes … the completion of CytRx’s previously announced, non-dilutive monetization strategy for its non-core assets.
“This could be a game-changing transaction
8-K
EX-99.1
LADX
LadRx Corp
6 Dec 96
Other events
12:00am
combination is a
successful example of CytRx's strategy to create wholly-owned subsidiaries
around distinct technology platforms, develop value … oral and mucosal vaccine
delivery. Our strategy will be to license these three technologies on a
vaccine-by-vaccine basis to companies engaged
DEFA14A
LADX
LadRx Corp
13 Aug 20
Additional proxy soliciting materials
8:16am
or alternative strategy to deserve consideration from stockholders.
We contend that the dissident has demonstrated that he is completely oblivious when … it comes to the key details pertaining to CytRx’s business, licensing agreements and strategy. Despite our repeated attempts to initiate a private dialogue
8-K
EX-99.1
LADX
LadRx Corp
3 Sep 20
CytRx Announces Voting Results from 2020 Annual Meeting and Issues New Investor Presentation
4:23pm
will maintain the continuity they need to continue executing on CytRx’s value-enhancing strategy. Looking ahead to 2021, we believe there is significant … and remaining committed to our disciplined strategy over the next year, we believe that CytRx will be able to build on that momentum. Although
8-K
EX-99
86gfrmgpxcpnjzfcd
7 May 18
CytRx Corporation Names Eric L. Curtis
5:24pm
8-K
EX-99.1
rpf7qzvd
20 Jan 04
Financial statements and exhibits
12:00am
424B3
hln4k
7 Aug 03
Prospectus supplement
12:00am
S-3
h4fn 16oodljvlx63
5 Nov 97
Shelf registration
12:00am
10-K405/A
EX-99.1
80ajcb78vxs
26 May 98
Annual report (delinquent filer disclosure) (amended)
12:00am
10-K405
ezbm1m
30 Mar 98
Annual report (delinquent filer disclosure)
12:00am